Creegan & Nassoura Financial Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.74M | Sell |
25,192
-5,185
| -17% | -$358K | 1.13% | 33 |
|
2025
Q1 | $2.06M | Hold |
30,377
| – | – | 1.37% | 31 |
|
2024
Q4 | $1.36M | Sell |
30,377
-5,264
| -15% | -$236K | 0.92% | 40 |
|
2024
Q3 | $2.24M | Sell |
35,641
-790
| -2% | -$49.7K | 1.41% | 31 |
|
2024
Q2 | $2.15M | Hold |
36,431
| – | – | 1.48% | 27 |
|
2024
Q1 | $2.91M | Hold |
36,431
| – | – | 1.94% | 14 |
|
2023
Q4 | $2.88M | Buy |
36,431
+4,583
| +14% | +$362K | 2.09% | 15 |
|
2023
Q3 | $2.22M | Sell |
31,848
-200
| -0.6% | -$14K | 1.73% | 21 |
|
2023
Q2 | $2.22M | Hold |
32,048
| – | – | 1.64% | 26 |
|
2023
Q1 | $2.38M | Buy |
32,048
+7,731
| +32% | +$574K | 1.83% | 20 |
|
2022
Q4 | $2.27M | Hold |
24,317
| – | – | 1.77% | 20 |
|
2022
Q3 | $2.32M | Hold |
24,317
| – | – | 2.01% | 18 |
|
2022
Q2 | $2.25M | Sell |
24,317
-250
| -1% | -$23.2K | 1.89% | 20 |
|
2022
Q1 | $2.49M | Sell |
24,567
-60
| -0.2% | -$6.07K | 1.86% | 22 |
|
2021
Q4 | $2.54M | Sell |
24,627
-300
| -1% | -$30.9K | 1.92% | 20 |
|
2021
Q3 | $2.12M | Sell |
24,927
-100
| -0.4% | -$8.49K | 1.8% | 21 |
|
2021
Q2 | $2.09M | Sell |
25,027
-800
| -3% | -$66.7K | 1.79% | 23 |
|
2021
Q1 | $1.94M | Sell |
25,827
-850
| -3% | -$63.9K | 1.73% | 24 |
|
2020
Q4 | $1.82M | Sell |
26,677
-100
| -0.4% | -$6.83K | 1.75% | 25 |
|
2020
Q3 | $1.56M | Hold |
26,777
| – | – | 1.68% | 27 |
|
2020
Q2 | $1.74M | Sell |
26,777
-1
| -0% | -$65 | 1.96% | 20 |
|
2020
Q1 | $1.59M | Hold |
26,778
| – | – | 2.07% | 17 |
|
2019
Q4 | $1.99M | Buy |
+26,778
| New | +$1.99M | 2% | 18 |
|
2016
Q1 | – | Sell |
-2,439
| Closed | -$238K | – | 75 |
|
2015
Q4 | $238K | Hold |
2,439
| – | – | 0.27% | 72 |
|
2015
Q3 | $235K | Hold |
2,439
| – | – | 0.27% | 72 |
|
2015
Q2 | $256K | Hold |
2,439
| – | – | 0.27% | 69 |
|
2015
Q1 | $252K | Hold |
2,439
| – | – | 0.26% | 72 |
|
2014
Q4 | $235K | Buy |
+2,439
| New | +$235K | 0.24% | 72 |
|